Heterogeneity of Breast Cancer Genomes: Going Beyond Therapy to Risk Assessment and Prevention

Heterogeneity of Breast Cancer Genomes: Going Beyond Therapy to Risk Assessment and Prevention

Explore the complexities of breast cancer genomics in this keynote presentation from the Cancer Genomics Consortium (CGC) 2023 Annual Meeting. Delve into the heterogeneity of breast cancer genomes, moving beyond therapy to focus on risk assessment and prevention strategies. Listen as Dr. Olufunmilayo Olopade, introduced by Gordana Raca, shares insights on cutting-edge research and its implications for patient care. Gain valuable knowledge about clinical cancer genomics, accurate diagnosis of underlying genomic alterations, and the potential for personalized treatment approaches. Discover how the Cancer Genomics Consortium is working towards ensuring all cancer patients receive the most appropriate therapy based on their genomic profile.